source
- How Kyverna rode CAR T’s autoimmune wave to the FDA’s doorPoised to become the first company to achieve a regulatory filing for a cell therapy in autoimmune disease, Kyverna Therapeutics is building a pipeline-in-a-product to change the treatment paradigm.BioSpace · 10d ago↗ source
- Early Alert: Intravascular Administration Set Issue from BaxterBaxter administration sets may have air bubbles in the drip chamber and tubing, which may result in air being delivered through the IV line to the patient.fda medwatch · 10d ago↗ source
- Opinion: Beware the unintended consequences of testosterone screening for military servicemembers“I fear that the widespread rollout of testosterone screening may lead to some surprising and unintended consequences,” writes a urologist who studies testosterone.